glp 1 drugs and kidney function TrimRX Renal effects of GLP-1 receptor
Description
By buying a high-dose pen and taking tiny doses, they can stretch a single months supply into several months
The two groups had comparable cancer risks in patients with and without diabetes
This discrepancy underscores the complexity of translating clinical trial results into broader patient populations and suggests that the impact of short-acting GLP-1 RAs on kidney outcomes may vary depending on specific clinical contexts
Consistent results were also found for patients with diabetes [14]
Results Seven trials (6609 participants) were included
Severe nausea leads to skipped doses
